Gastric Cancer in Brunei Darussalam: Epidemiological Trend Over a 27 Year Period (1986-2012)

  • Published : 2014.09.15


Background: Gastric cancer is the second most common gastrointestinal cancer and is more common in the East, compared to the West. This study assesses the trend of gastric cancers in Brunei Darussalam, a developing nation with a predominantly Malay population. Materials and Methods: The cancer registry from 1986 to 2012 maintained by the Department of Pathology, the only State Laboratory at the RIPAS Hospital, Ministry of Health, was reviewed and data extracted for analyses. The age standardised rate (ASR) and age specific incidence rate were calculated based on the projected population. Cancers diagnosed below 45 years were categorised as young gastric cancer. Results: Over the study period, there were a total of 551 cases of gastric cancer diagnosed. The most common type was adenocarcinoma (87.9%), followed by lymphoma (6.1%) and gastrointestinal stromal tumour (2.8%). The overall mean age at diagnosis was 61.9 years old (range 15 to 98) with an increasing trend observed, but this was not significant (ANOVA). There were differences in the mean age at diagnosis for the different races (p=0.003 for trend), but not the gender (p=0.105). Young gastric cancer accounted for 14.9%, being more common in women, and in Expatriate and Malay populations compared to the Chinese. There was a decrease in the ASR, from 17.3/100,000 in 1986-1990 to 12.5/100,000 in 2006-2010. Chinese had a higher overall ASR (20.2/100,000) compared to the Malays (11.8/100,000). The age specific rates were comparable between men and women until the age group 55-59 years when the rates started to diverge, becoming higher in men. Chinese men had higher rates then Malay men whereas, the rates were higher or comparable between the women until the age group >70 when the rate for Chinese women overtook their Malay counterpart. Conclusions: Our study showed that there is a declining trend in the incidence of gastric cancer and higher rates were observed in men and Chinese.


  1. Atrkar-Roushan Z, Kazemnejad A, Mansour-Ghanaei F, Zayeri F (2013). Trend analysis of gastrointestinal cancer incidences in Guilan province: comparing rates over 15 years. Asian Pac J Cancer Prev, 14, 7587-93.
  2. Bertuccio P Grabsch HI, Tan P (2013). Gastric cancer pathology and underlying molecular mechanisms. Dig Surg, 30, 150-8.
  3. Bertuccio P, Rosato V, Andreano A, et al (2013). Dietary patterns and gastric cancer risk: a systematic review and metaanalysis. Ann Oncol, 24, 1450-8.
  4. Chong VH, Lim KC, Rajendran N (2008). Prevalence of active Helicobacter pylori infection among patients referred for endoscopy in Brunei Darussalam. Singapore Med J, 49, 42-6.
  5. Cover TL, Peek RM Jr (2013). Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes, 4, 482-93.
  6. de Martel C, Forman D, Plummer M (2013). Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am, 42, 219-40.
  7. Deans C, Yeo MS, Soe MY, et al (2011). Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg, 35, 617-24.
  8. Fock KM, Ang TL (2010). Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol, 25, 479-86.
  9. Goh KL (2009). Epidemiology of Helicobacter pylori infection in Malaysia--observations in a multiracial Asian population. Med J Malaysia, 64, 187-92.
  10. Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N (2007). Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: A prospective case control study. Am J Gastroenterol, 102, 40-5.
  11. He CZ, Zhang KH (2013). Serum protein and genetic tumor markers of gastric carcinoma. Asian Pac J Cancer Prev, 14, 3437-42.
  12. International Agency for Research on Cancer (IARC). GLOBOCAN 2012. (accessed 15th April 2014).
  13. Lim SH, Kwon JW, Kim N, et al (2013). Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol, 13, 104.
  14. Look M, Gao F, Low CH, Nambiar R (2001). Gastric cancer in Singapore. Gastric Cancer, 4, 219-22.
  15. Lu YF, Liu ZC, Li ZH, et al (2014). Esophageal/gastric cancer screening in high-risk populations in Henan Province, China. Asian Pac J Cancer Prev, 15, 1419-22.
  16. Figueiredo C, Garcia-Gonzalez MA, Machado JC (2013). Molecular pathogenesis of gastric cancer. Helicobacter, 18, 28-33.
  17. Pandey R, Misra V, Misra SP, et al (2010). Helicobacter pylori and gastric cancer. Asian Pac J Cancer Prev, 11, 583-8.
  18. Shafaghi A, Mansour-Ghanaei F, Joukar F, et al (2013). Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac J Cancer Prev, 14, 3931-6.
  19. Sano H, Goto R, Hamashima C (2014). What is the most effective strategy for improving the cancer screening rate in Japan? Asian Pac J Cancer Prev, 15, 2607-12.
  20. Sepulveda AR (2013). Helicobacter, inflammation, and gastric cancer. Curr Pathobiol Rep, 1, 9-18.
  21. Suh M, Choi KS, Lee YY, Park B, Jun JK (2013). Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev, 14, 6459-63.

Cited by

  1. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo vol.12, pp.1, 2015,
  2. Profiles of Epstein-Barr Virus Associated Gastric Carcinomas in Brunei Darussalam vol.15, pp.23, 2015,
  3. Risk Factors and Epidemiology of Gastric Cancer in Pakistan vol.16, pp.12, 2015,
  4. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients vol.16, pp.16, 2015,
  5. Esophageal Cancer in Brunei Darussalam over a three Decade Period: an Epidemiologic Study of Trends and Differences between Genders and Racial Groups vol.16, pp.9, 2015,